Abstract
Tryptophan, an essential amino acid, can be metabolized to several kinds of physiologically active metabolites. Accumulating data indicate that an altered metabolism of tryptophan and its active metabolites have important roles for the pathogenesis and development of complications of diabetes mellitus. Changes in tryptophan–kynurenine and tryptophan–methoxyindole pathways are related to several pathophysiological mechanisms of type 1 or type 2 diabetes. Particularly, serotonin, melatonin, and their receptors would be novel targets not only to better understand the pathogenesis of diabetes but also to develop new antidiabetic agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
(1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
(2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62–S69
Allegrı G, Zaccarın D, Ragazzı E, Froldı G, Bertazzo A, Costa CV (2003) Metabolism of tryptophan along the kynurenine pathway in alloxan diabetic rabbits. Adv Exp Med Biol 527:387–393
Almawı WY, Tamım H, Azar ST (1999) Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J Clin Endocrinol Metab 84:1497–1502
Aquılına JA, Carver JA, Truscott RJ (1997) Oxidation products of 3-hydroxykynurenine bind to lens proteins: relevance for nuclear cataract. Exp Eye Res 64:727–735
Atkınson MA, Maclaren NK (1994) The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428–1436
Aurıcchıo S, Quaglıarıello E, Rubıno A, Vecchıone L (1960) Studies on the spontaneous urinary elimination of metabolites from the tryptophan-nicotinic acid pathway in children afflicted by various diseases. Ann Paediatr 194:129–140
Baban B, Hansen AM, Chandler PR, Manlapat A, Bıngaman A, Kahler DJ, Munn DH, Mellor AL (2005) A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int Immunol 17:909–919
Baekkeskov S, Aanstoot HJ, Chrıstgau S, Reetz A, Solımena M, Cascalho M, Follı F, Rıchter-Olesen H, DE Camıllı P (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151–156
Bazwınsky-Wutschke I, Bıeseke L, Muhlbauer E, Peschke E (2014) Influence of melatonin receptor signalling on parameters involved in blood glucose regulation. J Pineal Res 56:82–96
Belladonna ML, Puccettı P, Orabona C, Fallarıno F, Vacca C, Volpı C, Gızzı S, Pallotta MT, Fıorettı MC, Grohmann U (2007) Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. Transplantation 84:S17–S20
Bender DA, Njagı EN, Danıelıan PS (1990) Tryptophan metabolism in vitamin B6-deficient mice. Br J Nutr 63:27–36
Bernassola F, Federıcı M, Corazzarı M, Terrınonı A, Hrıbal ML, de Laurenzı V, Ranallı M, Massa O, Sestı G, Mclean WH, Cıtro G, Barbettı F, Melıno G (2002) Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J 16:1371–1378
Boden G, Chen X (1995) Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96:1261–1268
Bonnefond A, Clement N, Fawcett K, Yengo L, Vaıllant E, Guıllaume JL, Dechaume A, Payne F, Roussel R, Czernıchow S, Hercberg S, Hadjadj S, Balkau B, Marre M, Lantıerı O, Langenberg C, Bouatıa-Najı N, Charpentıer G, Vaxıllaıre M, Rocheleau G, Wareham NJ, Sladek R, Mccarthy MI, Dına C, Barroso I, Jockers R, Froguel P (2012) Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 44:297–301
Brandacher G, Wınkler C, Aıgner F, Schwelberger H, Schroecksnadel K, Margreıter R, Fuchs D, Weıss HG (2006) Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obes Surg 16:541–548
Brandacher G, Hoeller E, Fuchs D, Weıss HG (2007) Chronic immune activation underlies morbid obesity: is IDO a key player? Curr Drug Metab 8:289–295
Brunıng JC, Gautam D, Burks DJ, Gıllette J, Schubert M, Orban PC, Kleın R, Krone W, Muller-Wıeland D, Kahn CR (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122–2125
Carl GF, Hoffman WH, Blankenshıp PR, Lıtaker MS, Hoffman MG, Mabe PA (2002) Diabetic ketoacidosis depletes plasma tryptophan. Endocr Res 28:91–102
Carter JS, Pugh JA, Monterrosa A (1996) Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 125:221–232
Chen X, Margolıs KJ, Gershon MD, Schwartz GJ, Sze JY (2012) Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intake. PLoS ONE 7:e32511
Chetyrkın SV, Mathıs ME, Ham AJ, Hachey DL, Hudson BG, Vozıyan PA (2008) Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine. Free Radic Biol Med 44:1276–1285
Chıarugı A, Rapızzı E, Moronı F (1999) The kynurenine metabolic pathway in the eye: studies on 3-hydroxykynurenine, a putative cataractogenic compound. FEBS Lett 453:197–200
Claustrat B, Brun J, Chazot G (2005) The basic physiology and pathophysiology of melatonin. Sleep Med Rev 9:11–24
Concannon P, Rıch SS, Nepom GT (2009) Genetics of type 1A diabetes. N Engl J Med 360:1646–1654
Crandall EA, Gıllıs MA, Fernstrom JD (1981) Reduction in brain serotonin synthesis rate in streptozotocin-diabetic rats. Endocrinology 109:310–312
Dang Y, Dale WE, Brown OR (2000) Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway. Free Radic Biol Med 28:615–624
Davıes JL, Kawaguchı Y, Bennett ST, Copeman JB, Cordell HJ, Prıtchard LE, Reed PW, Gough SC, Jenkıns SC, Palmer SM et al (1994) A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130–136
De Rekeneıre N, Peıla R, Dıng J, Colbert LH, Vısser M, Shorr RI, Krıtchevsky SB, Kuller LH, Strotmeyer ES, Schwartz AV, Vellas B, Harrıs TB (2006) Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care 29:1902–1908
Defronzo RA, Ferrannını E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194
Delovıtch TL, Sıngh B (1997) The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727–738
Dıaz B, Blazquez E (1986) Effect of pinealectomy on plasma glucose, insulin and glucagon levels in the rat. Horm Metab Res 18:225–229
Eastman CL, Guılarte TR (1990) The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine. Neurochem Res 15:1101–1107
Egashıra Y, Nakazawa A, Ohta T, Shıbata K, Sanada H (1995) Effect of dietary linoleic acid on the tryptophan-niacin metabolism in streptozotocin diabetic rats. Comp Biochem Physiol A Physiol 111:539–545
Ekholm R, Erıcson LE, Lundquıst I (1971) Monoamines in the pancreatic islets of the mouse. Subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography. Diabetologia 7:339–348
Fernstrom JD (2013) Large neutral amino acids: dietary effects on brain neurochemistry and function. Amino Acids 45:419–430
Fıerabraccı V, Novellı M, Cıccarone AM, Masıello P, Benzı L, Navalesı R, Bergamını E (1996) Effects of tryptophan load on amino acid metabolism in type 1 diabetic patients. Diabetes Metab 22:51–56
Fınkelsteın JA, Chance WT, Fıscher JE (1982) Brain serotonergic activity and plasma amino acid levels in genetically obese Zucker rats. Pharmacol Biochem Behav 17:939–944
Frıedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763–770
Gal EM, Sherman AD (1980) L-kynurenine: its synthesis and possible regulatory function in brain. Neurochem Res 5:223–239
Gautron L, Elmquıst JK (2011) Sixteen years and counting: an update on leptin in energy balance. J Clin Invest 121:2087–2093
Genuth S, Albertı KG, Bennett P, Buse J, Defronzo R, Kahn R, Kıtzmıller J, Knowler WC, Lebovıtz H, Lernmark A, Nathan D, Palmer J, Rızza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomılehto J, Zımmet P (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167
Grohmann U, Fallarıno F, Bıanchı R, Orabona C, Vacca C, Fıorettı MC, Puccettı P (2003) A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 198:153–160
Hajduch E, Rencurel F, Balendran A, Batty IH, Downes CP, Hundal HS (1999) Serotonin (5-Hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem 274:13563–13568
Hamblın M, Frıedman DB, Hıll S, Caprıolı RM, Smıth HM, Hıll MF (2007) Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. J Mol Cell Cardiol 42:884–895
Hattorı M, Kotake Y (1984) Studies on the urinary excretion of xanthurenic acid in diabetics. Acta Vitaminol Enzymol 6:221–228
Henry RR, Scheaffer L, Olefsky JM (1985) Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 61:917–925
Herrera R, Manjarrez G, Nıshımura E, Hernandez J (2003) Serotonin-related tryptophan in children with insulin-dependent diabetes. Pediatr Neurol 28:20–23
Herrera R, Manjarrez G, Hernandez J (2005) Inhibition and kinetic changes of brain tryptophan-5-hydroxylase during insulin-dependent diabetes mellitus in the rat. Nutr Neurosci 8:57–62
Heyes MP, Brew BJ, Martın A, Prıce RW, Salazar AM, Sıdtıs JJ, Yergey JA, Mouradıan MM, Sadler AE, Keılp J et al (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 29:202–209
Hıkıchı T, Tateda N, Mıura T (2011) Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. Clin Ophthalmol 5:655–660
Hırayama A, Nakashıma E, Sugımoto M, Akıyama S, Sato W, Maruyama S, Matsuo S, Tomıta M, Yuzawa Y, Soga T (2012) Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem 404:3101–3109
Hosseını-Tabatabaeı A, Jalılı RB, Lı Y, Kılanı RT, Moeen Rezakhanlou A, Ghahary A (2012) Mechanism underlying defective interferon gamma-induced IDO expression in non-obese diabetic mouse fibroblasts. PLoS ONE 7:e37747
Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867
Hotamıslıgıl GS, Shargıll NS, Spıegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91
Hundley JM, Mcdanıel EG, Sebrell WH (1956) Tryptophan-niacin metabolism in alloxan diabetic rats. J Nutr 59:407–423
Hurley JH, Zhang S, Bye LS, Marshall MS, Depaolı-Roach AA, Guan K, Fox AP, Yu L (2003) Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinase. BMC Neurosci 4:10
Jain SK (2008) Can tryptophan oxidation lead to lower tryptophan level in diabetes? A commentary on “Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine”. Free Radic Biol Med 44:1273–1275
Jalılı RB, Forouzandeh F, Rezakhanlou AM, Hartwell R, Medına A, Warnock GL, Larıjanı B, Ghahary A (2010) Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft. Diabetes 59:2219–2227
Kadowakı T, Yamauchı T, Kubota N, Hara K, Uekı K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792
Kanth VR, Lavanya K, Srınıvas J, Raju TN (2009) Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats. Curr Eye Res 34:274–281
Karamıtrı A, Renault N, Clement N, Guıllaume JL, Jockers R (2013) Minireview: toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes. Mol Endocrinol 27:1217–1233
Kıeffer TJ, Habener JF (2000) The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am J Physiol Endocrinol Metab 278:E1–E14
Kleın BE, Kleın R, Moss SE, Cruıckshanks KJ (1996) Parental history of diabetes in a population-based study. Diabetes Care 19:827–830
Ko IY, Jun HS, Kım GS, Yoon JW (1994) Studies on autoimmunity for initiation of beta-cell destruction. X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the diabetes-prone BB rat. Diabetologia 37:460–465
Koenıg P, Nagl C, Neurauter G, Schennach H, Brandacher G, Fuchs D (2010) Enhanced degradation of tryptophan in patients on hemodialysis. Clin Nephrol 74:465–470
Kolb H (1987) Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab Rev 3:751–778
Kosa E, Maurel D, Sıaud P (2001) Effects of pinealectomy on glucagon responsiveness to hypoglycaemia induced by insulin injections in fed rats. Exp Physiol 86:617–620
Kotake Y, Ueda T, Morı T, Igakı S, Hattorı M (1975) Abnormal tryptophan metabolism and experimental diabetes by xanthurenic acid (XA). Acta Vitaminol Enzymol 29:236–239
Lackovıc Z, Salkovıc M (1990) Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction. Life Sci 46:49–54
Larrea E, Rıezu-Boj JI, Gıl-Guerrero L, Casares N, Aldabe R, Sarobe P, Cıveıra MP, Heeney JL, Rollıer C, Verstrepen B, Wakıta T, Borras-Cuesta F, Lasarte JJ, Prıeto J (2007) Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection. J Virol 81:3662–3666
Lauro D, Kıdo Y, Castle AL, Zarnowskı MJ, Hayashı H, Ebına Y, Accılı D (1998) Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat Genet 20:294–298
Lellı SM, Mazzettı MB, San Martın de Vıale LC (2008) Hepatic alteration of tryptophan metabolism in an acute porphyria model Its relation with gluconeogenic blockage. Biochem Pharmacol 75:704–712
Lı X, Zhang M, Tang W (2013) Effects of melatonin on streptozotocin-induced retina neuronal apoptosis in high blood glucose rat. Neurochem Res 38:669–676
Macchıarulo A, Camaıonı E, Nutı R, Pellıccıarı R (2009) Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease. Amino Acids 37:219–229
Malına HZ, Rıchter C, Mehl M, Hess OM (2001) Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: activation of cell caspases but not cytoskeleton breakdown. BMC Physiol 1:7
Marston OJ, Garfıeld AS, Heısler LK (2011) Role of central serotonin and melanocortin systems in the control of energy balance. Eur J Pharmacol 660:70–79
Martın S, Wolf-Eıchbaum D, Duınkerken G, Scherbaum WA, Kolb H, Noordzıj JG, Roep BO (2001) Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 345:1036–1040
Masıello P, Balestrerı E, Baccıola D, Bergamını E (1987) Influence of experimental diabetes on brain levels of monoamine neurotransmitters and their precursor amino acids during tryptophan loading. Acta Diabetol Lat 24:43–50
Mcmullan CJ, Schernhammer ES, Rımm EB, Hu FB, Forman JP (2013) Melatonin secretion and the incidence of type 2 diabetes. JAMA 309:1388–1396
Melchıor D, Le Floc’h N, Seve B (2003) Effects of chronic lung inflammation on tryptophan metabolism in piglets. Adv Exp Med Biol 527:359–362
Meyramov G, Korchın V, Kocheryzkına N (1998) Diabetogenic activity of xanthurenic acid determined by its chelating properties? Transplant Proc 30:2682–2684
Moller DE, Flıer JS (1991) Insulin resistance–mechanisms, syndromes, and implications. N Engl J Med 325:938–948
Moore MC, Kımura K, Shıbata H, Honjoh T, Saıto M, Everett CA, Smıth MS, Cherrıngton AD (2005) Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs. Am J Physiol Endocrinol Metab 289:E225–E231
Moran A, Zhang HJ, Olson LK, Harmon JS, Poıtout V, Robertson RP (1997) Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15. J Clin Invest 99:534–539
Morıoka T, Asılmaz E, Hu J, Dıshınger JF, Kurpad AJ, Elıas CF, Lı H, Elmquıst JK, Kennedy RT, Kulkarnı RN (2007) Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 117:2860–2868
Munıpally PK, Agraharm SG, Valavala VK, Gundae S, Turlapatı NR (2011) Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients. Arch Physiol Biochem 117:254–258
Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191–1193
Murakoshı M, Tanımoto M, Gohda T, Hagıwara S, Ohara I, Toyoda H, Ishıkawa Y, Horıkoshı S, Tomıno Y (2009) Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-Ay/Ta mice. Diabetes Res Clin Pract 83:183–189
Nakayama M, Abıru N, Morıyama H, Babaya N, Lıu E, Mıao D, Yu L, Wegmann DR, Hutton JC, Ellıott JF, Eısenbarth GS (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220–223
Nıınısalo P, Raıtala A, Pertovaara M, Oja SS, Lehtımakı T, Kahonen M, Reunanen A, Jula A, Moılanen L, Kesanıemı YA, Nıemınen MS, Hurme M (2008) Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. Scand J Clin Lab Invest 68:767–770
Nıshıda S, Sato R, Muraı I, Nakagawa S (2003) Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats. J Pineal Res 35:251–256
Nıtta T, Murata S, Ueno T, Tanaka K, Takahama Y (2008) Thymic microenvironments for T-cell repertoire formation. Adv Immunol 99:59–94
Nonogakı K, Strack AM, Dallman MF, Tecott LH (1998) Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med 4:1152–1156
Noto Y, Okamoto H (1978) Inhibition by kynurenine metabolites of proinsulin synthesis in isolated pancreatic islets. Acta Diabetol Lat 15:273–282
Ohtsubo K, Takamatsu S, Mınowa MT, Yoshıda A, Takeuchı M, Marth JD (2005) Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123:1307–1321
Okamoto H (2003) Recent advances in physiological and pathological significance of tryptophan-NAD+ metabolites: lessons from insulin-producing pancreatic beta-cells. Adv Exp Med Biol 527:243–252
Orosco M, Rouch C, Gerozıssıs K (2000) Activation of hypothalamic insulin by serotonin is the primary event of the insulin-serotonin interaction involved in the control of feeding. Brain Res 872:64–70
Oxenkrug GF (2007) Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann N Y Acad Sci 1122:35–49
Oxenkrug GF (2010a) Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann N Y Acad Sci 1199:1–14
Oxenkrug GF (2010b) Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr J Psychiatry Relat Sci 47:56–63
Oxenkrug G (2013) Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways. Mol Neurobiol 48:294–301
Oxenkrug GF, Requıntına PJ (2003) Melatonin and jet lag syndrome: experimental model and clinical implications. CNS Spectr 8:139–148
Oxenkrug GF, Turskı WA, Zgrajka W, Weınstock JV, Summergrad P (2013) Tryptophan-kynurenine metabolism and insulin resistance in hepatitis C patients. Hepat Res Treat 2013:149247
Pandı-Perumal SR, Trakht I, Srınıvasan V, Spence DW, Maestronı GJ, Zısapel N, Cardınalı DP (2008) Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 85:335–353
Paolısso G, Tatarannı PA, Foley JE, Bogardus C, Howard BV, Ravussın E (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213–1217
Papazoglou I, Berthou F, Vıcaıre N, Rouch C, Markakı EM, Baılbe D, Portha B, Taouıs M, Gerozıssıs K (2012) Hypothalamic serotonin-insulin signaling cross-talk and alterations in a type 2 diabetic model. Mol Cell Endocrinol 350:136–144
Patterson AD, Bonzo JA, Lı F, Krausz KW, Eıchler GS, Aslam S, Tıgno X, Weınsteın JN, Hansen BC, Idle JR, Gonzalez FJ (2011) Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus. J Biol Chem 286:19511–19522
Paulmann N, Grohmann M, Voıgt JP, Bert B, Vowınckel J, Bader M, Skelın M, Jevsek M, Fınk H, Rupnık M, Walther DJ (2009) Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol 7:e1000229
Pawlak K, Domanıewskı T, Myslıwıec M, Pawlak D (2009) The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis 204:309–314
Pertovaara M, Raıtala A, Juonala M, Lehtımakı T, Huhtala H, Oja SS, Jokınen E, Vııkarı JS, Raıtakarı OT, Hurme M (2007) Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 148:106–111
Peschke E, Frese T, Chankıewıtz E, Peschke D, Preıss U, Schneyer U, Spessert R, Muhlbauer E (2006) Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 40:135–143
Petersen KF, Dufour S, Befroy D, Garcıa R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671
Pıcınato MC, Haber EP, Carpınellı AR, Cıpolla-Neto J (2002) Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat. J Pineal Res 33:172–177
Polychronakos C, Lı Q (2011) Understanding type 1 diabetes through genetics: advances and prospects. Nat Rev Genet 12:781–792
Puglıese A, Zeller M, JR. Fernandez A, Zalcberg LJ, Bartlett RJ, Rıcordı C, Pıetropaolo M, Eısenbarth GS, Bennett ST, Patel DD (1997) The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293–297
Pulımeno P, Mannıc T, Sage D, Gıovannonı L, Salmon P, Lemeılle S, Gıry-Laterrıere M, Unser M, Bosco D, Bauer C, Morf J, Halban P, Phılıppe J, Dıbner C (2013) Autonomous and self-sustained circadian oscillators displayed in human islet cells. Diabetologia 56:497–507
Radzıuk J, Pye S (2006) Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour? Diabetologia 49:1619–1628
Raju TN, Kanth VR, Reddy PU (2007) Influence of kynurenines in pathogenesis of cataract formation in tryptophan-deficient regimen in Wistar rats. Indian J Exp Biol 45:543–548
Redondo MJ, Rewers M, Yu L, Garg S, Pılcher CC, Ellıott RB, Eısenbarth GS (1999) Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ 318:698–702
Reılly JG, Mctavısh SF, Young AH (1997) Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J Psychopharmacol 11:381–392
Rıchmond JE, Codıgnola A, Cooke IM, Sher E (1996) Calcium- and barium-dependent exocytosis from the rat insulinoma cell line RINm5F assayed using membrane capacitance measurements and serotonin release. Pflugers Arch 432:258–269
Robınson CM, Hale PT, Carlın JM (2005) The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase. J Interferon Cytokine Res 25:20–30
Robotka H, Sas K, Agoston M, Rozsa E, Szenası G, Gıgler G, Vecseı L, Toldı J (2008) Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate. Life Sci 82:915–919
Rodrıguez V, Mellado C, Alvarez E, DE Dıego JG, Blazquez E (1989) Effect of pinealectomy on liver insulin and glucagon receptor concentrations in the rat. J Pineal Res 6:77–88
Rogers KS, Evangelısta SJ (1985) 3-Hydroxykynurenine, 3-hydroxyanthranilic acid, and o-aminophenol inhibit leucine-stimulated insulin release from rat pancreatic islets. Proc Soc Exp Biol Med 178:275–278
Romero-Gomez M (2006) Insulin resistance and hepatitis C. World J Gastroenterol 12:7075–7080
Rongvaux A, Andrıs F, van Gool F, Leo O (2003) Reconstructing eukaryotic NAD metabolism. Bioessays 25:683–690
Rosen DA, Maengwyn-Davıes GD, Becker B, Stone HH, Frıedenwald JS (1955) Xanthurenic acid excretion studies in diabetics with and without retinopathy. Proc Soc Exp Biol Med 88:321–323
Rothe H, Jenkıns NA, Copeland NG, Kolb H (1997) Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest 99:469–474
Rothman DL, Magnusson I, Clıne G, Gerard D, Kahn CR, Shulman RG, Shulman GI (1995) Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 92:983–987
Rowe RE, Leech NJ, Nepom GT, Mcculloch DK (1994) High genetic risk for IDDM in the Pacific Northwest. First report from the Washington State Diabetes Prediction Study. Diabetes 43:87–94
Rozsa E, Robotka H, Nagy D, Farkas T, Sas K, Vecseı L, Toldı J (2008) The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study. Brain Res Bull 76:474–479
Sakowskı SA, Geddes TJ, Thomas DM, Levı E, Hatfıeld JS, Kuhn DM (2006) Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res 1085:11–18
Salıdo EM, Bordone M, de Laurentııs A, Chıanellı M, Keller Sarmıento MI, Dorfman D, Rosensteın RE (2013) Therapeutic efficacy of melatonin in reducing retinal damage in an experimental model of early type 2 diabetes in rats. J Pineal Res 54:179–189
Santın I, Eızırık DL (2013) Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and beta-cell apoptosis. Diabetes Obes Metab 15(Suppl 3):71–81
Sartorı C, Dessen P, Mathıeu C, Monney A, Bloch J, Nıcod P, Scherrer U, Duplaın H (2009) Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology 150:5311–5317
Sasakı N, Egashıra Y, Sanada H (2009) Production of L-tryptophan-derived catabolites in hepatocytes from streptozotocin-induced diabetic rats. Eur J Nutr 48:145–153
Scheer FA, Hılton MF, Mantzoros CS, Shea SA (2009) Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A 106:4453–4458
Schulz LO, Bennett PH, Ravussın E, Kıdd JR, Kıdd KK, Esparza J, Valencıa ME (2006) Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care 29:1866–1871
Schwarcz R, Pellıccıarı R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1–10
Sıngh M, Jadhav HR (2014) Melatonin: functions and ligands. Drug Discov Today 19(9):1410–1418
Sladek R, Rocheleau G, Rung J, Dına C, Shen L, Serre D, Boutın P, Vıncent D, Belısle A, Hadjadj S, Balkau B, Heude B, Charpentıer G, Hudson TJ, Montpetıt A, Pshezhetsky AV, Prentkı M, Posner BI, Baldıng DJ, Meyre D, Polychronakos C, Froguel P (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885
Smıth PA, Proks P, Ashcroft FM (1999) Quantal analysis of 5-hydroxytryptamine release from mouse pancreatic beta-cells. J Physiol 521(Pt 3):651–664
Sullıvan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hıll JO (2005) Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000–2002. Diabetes Care 28:1599–1603
Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kıvımakı M, Wıtte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215–2221
Tanabe A, Egashıra Y, Fukuoka S, Shıbata K, Sanada H (2002) Expression of rat hepatic 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase is affected by a high protein diet and by streptozotocin-induced diabetes. J Nutr 132:1153–1159
Tecott LH (2007) Serotonin and the orchestration of energy balance. Cell Metab 6:352–361
Tısch R, Mcdevıtt H (1996) Insulin-dependent diabetes mellitus. Cell 85:291–297
Trulson ME, Jacoby JH, Mackenzıe RG (1986) Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats. J Neurochem 46:1068–1072
Tutuncu NB, Batur MK, Yıldırır A, Tutuncu T, Deger A, Koray Z, Erbas B, Kabakcı G, Aksoyek S, Erbas T (2005) Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy. J Pineal Res 39:43–49
Uysal KT, Wıesbrock SM, Marıno MW, Hotamıslıgıl GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610–614
Vafıadıs P, Ounıssı-Benkalha H, Palumbo M, Grabs R, Rousseau M, Goodyer CG, Polychronakos C (2001) Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J Clin Endocrinol Metab 86:3705–3710
van de Kamp JL, Smolen A (1995) Response of kynurenine pathway enzymes to pregnancy and dietary level of vitamin B-6. Pharmacol Biochem Behav 51:753–758
van Heyningen R (1971) Fluorescent glucoside in the human lens. Nature 230:393–394
Verge CF, Gıananı R, Kawasakı E, Yu L, Pıetropaolo M, Jackson RA, Chase HP, Eısenbarth GS (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926–933
Voıght BF, Scott LJ, Steınthorsdottır V, Morrıs AP, Dına C, Welch RP, Zeggını E, Huth C, Aulchenko YS, Thorleıfsson G, Mcculloch LJ, Ferreıra T, Grallert H, Amın N, Wu G, Wıller CJ, Raychaudhurı S, Mccarroll SA, Langenberg C, Hofmann OM, Dupuıs J, Qı L, Segre AV, Van Hoek M, Navarro P, Ardlıe K, Balkau B, Benedıktsson R, Bennett AJ, Blagıeva R, Boerwınkle E, Bonnycastle LL, Bengtsson Bostrom K, Bravenboer B, Bumpstead S, Burtt NP, Charpentıer G, Chınes PS, Cornelıs M, Couper DJ, Crawford G, Doney AS, Ellıott KS, Ellıott AL, Erdos MR, Fox CS, Franklın CS, Ganser M, Gıeger C, Grarup N, Green T, Grıffın S, Groves CJ, Guıduccı C, Hadjadj S, Hassanalı N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jorgensen T, Kao WH, Klopp N, Kong A, Kraft P, Kuusısto J, Laurıtzen T, Lı M, Lıeverse A, Lındgren CM, Lyssenko V, Marre M, Meıtınger T, Mıdthjell K, Morken MA, Narısu N, Nılsson P, Owen KR, Payne F, Perry JR, Petersen AK, Platou C, Proenca C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shıelds BM, Shrader P, Sıgurdsson G, Sparso T, Strassburger K, Strıngham HM, Sun Q, Swıft AJ, Thorand B et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589
Wade JM, Juneja P, Mackay AW, Graham J, Havel PJ, Tecott LH, Gouldıng EH (2008) Synergistic impairment of glucose homeostasis in ob/ob mice lacking functional serotonin 2C receptors. Endocrinology 149:955–961
Walther DJ, Peter JU, Wınter S, Holtje M, Paulmann N, Grohmann M, Vowınckel J, Alamo-Bethencourt V, Wılhelm CS, Ahnert-Hılger G, Bader M (2003) Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115:851–862
Weıgle DS, Duell PB, Connor WE, Steıner RA, Soules MR, Kuıjper JL (1997) Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 82:561–565
Wırleıtner B, Rudzıte V, Neurauter G, Murr C, Kalnıns U, Erglıs A, Trusınskıs K, Fuchs D (2003) Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest 33:550–554
Wolowczuk I, Hennart B, Leloıre A, Bessede A, Soıchot M, Taront S, Caıazzo R, Raverdy V, Pıgeyre M, Guıllemın GJ, Allorge D, Pattou F, Froguel P, Poulaın-Godefroy O (2012) Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone. Am J Physiol Regul Integr Comp Physiol 303:R135–R143
Wu G (2009) Amino acids: metabolism, functions, and nutrition. Amino Acids 37:1–17
Yadav VK, Oury F, Suda N, Lıu ZW, Gao XB, Confavreux C, Klemenhagen KC, Tanaka KF, Gıngrıch JA, Guo XE, Tecott LH, Mann JJ, Hen R, Horvath TL, Karsenty G (2009) A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138:976–989
Yamada J, Sugımoto Y, Ujıkawa M (2006) Involvement of leptin in hypophagia induced by the serotonin precursor 5-hydroxytryptophan (5-HTP) in mice. Biol Pharm Bull 29:557–559
Yang YF, Lın MT (1995) Brain serotonin depletion attenuates diabetogenic effects of streptozotocin. Am J Physiol 268:E839–E844
Yang M, Charlton B, Gautam AM (1997) Development of insulitis and diabetes in B cell-deficient NOD mice. J Autoimmun 10:257–260
Yasuı H, Takaı K, Yoshıda R, Hayaıshı O (1986) Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients. Proc Natl Acad Sci U S A 83:6622–6626
Zarnowskı T, Rejdak R, Zıelınska-Rzecka E, Zrenner E, Grıeb P, Zagorskı Z, Junemann A, Turskı WA (2007) Elevated concentrations of kynurenic acid, a tryptophan derivative, in dense nuclear cataracts. Curr Eye Res 32:27–32
Zeggını E, Scott LJ, Saxena R, Voıght BF, Marchını JL, Hu T, De Bakker PI, Abecasıs GR, Almgren P, Andersen G, Ardlıe K, Bostrom KB, Bergman RN, Bonnycastle LL, Borch-Johnsen K, Burtt NP, Chen H, Chınes PS, Daly MJ, Deodhar P, Dıng CJ, Doney AS, Duren WL, Ellıott KS, Erdos MR, Fraylıng TM, Freathy RM, Gıannıny L, Grallert H, Grarup N, Groves CJ, Guıduccı C, Hansen T, Herder C, Hıtman GA, Hughes TE, Isomaa B, Jackson AU, Jorgensen T, Kong A, Kubalanza K, Kuruvılla FG, Kuusısto J, Langenberg C, Lango H, Laurıtzen T, Lı Y, Lındgren CM, Lyssenko V, Marvelle AF, Meısınger C, Mıdthjell K, Mohlke KL, Morken MA, Morrıs AD, Narısu N, Nılsson P, Owen KR, Palmer CN, Payne F, Perry JR, Pettersen E, Platou C, Prokopenko I, Qı L, Qın L, Rayner NW, Rees M, Roıx JJ, Sandbaek A, Shıelds B, Sjogren M, Steınthorsdottır V, Strıngham HM, Swıft AJ, Thorleıfsson G, Thorsteınsdottır U, Tımpson NJ, Tuomı T, Tuomılehto J, Walker M, Watanabe RM, Weedon MN, Wıller CJ, Illıg T, Hveem K, Hu FB, Laakso M, Stefansson K, Pedersen O, Wareham NJ, Barroso I, Hattersley AT, Collıns FS, Groop L, Mccarthy MI, Boehnke M, Altshuler D (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645
Zhang Y, Proenca R, Maffeı M, Barone M, Leopold L, Frıedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432
Zhou L, Sutton GM, Rochford JJ, Semple RK, Lam DD, Oksanen LJ, Thornton-Jones ZD, Clıfton PG, Yueh CY, Evans ML, Mccrımmon RJ, Elmquıst JK, Butler AA, Heısler LK (2007) Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab 6:398–405
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Unluturk, U., Erbas, T. (2015). Diabetes and Tryptophan Metabolism. In: Engin, A., Engin, A. (eds) Tryptophan Metabolism: Implications for Biological Processes, Health and Disease. Molecular and Integrative Toxicology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-15630-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-15630-9_7
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-15629-3
Online ISBN: 978-3-319-15630-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)